Literature evidence in open targets - a target validation platform.

Journal: Journal of biomedical semantics
Published Date:

Abstract

BACKGROUND: We present the Europe PMC literature component of Open Targets - a target validation platform that integrates various evidence to aid drug target identification and validation. The component identifies target-disease associations in documents and ranks the documents based on their confidence from the Europe PMC literature database, by using rules utilising expert-provided heuristic information. The confidence score of a given document represents how valuable the document is in the scope of target validation for a given target-disease association by taking into account the credibility of the association based on the properties of the text. The component serves the platform regularly with the up-to-date data since December, 2015.

Authors

  • Şenay Kafkas
    European Molecular Biology Laboratory (EMBL-EBI), European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, CB10 1SD, UK. kafkas@ebi.ac.uk.
  • Ian Dunham
    European Bioinformatics Institute (EMBL-EBI), European Molecular Biology Laboratory, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD UK ; Centre for Therapeutic Target Validation, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD UK.
  • Johanna McEntyre
    European Molecular Biology Laboratory (EMBL-EBI), European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, CB10 1SD, UK.